Home › Neuroblastoma › Oregon › Portland
Neuroblastoma clinical trials in Portland, OR
6 studies for Neuroblastoma are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Oregon Health and Science University ( Site 1004), Portland
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RecruitingPhase 2
- Randall Children's Hospital, Portland
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RecruitingPhase 2
- Randall Children's Hospital, Portland
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Legacy Emanuel Children's Hospital, Portland
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RecruitingPhase 2
- Randall Children's Hospital, Portland
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- New York City, NY12 studies
- Washington, DC11 studies
- Dallas, TX10 studies
- Cincinnati, OH9 studies
- St. Louis, MO9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Aurora, CO9 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Harrisburg, PA8 studies
Other studies in Portland
- Non-Small Cell Lung Cancer49 studies
- Cancer (all types)36 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Ovarian Cancer28 studies
- Colorectal Cancer28 studies
- Lung Cancer27 studies
- Acute Myeloid Leukemia24 studies
- Endometrial Cancer24 studies
- Pancreatic Cancer19 studies
- Head and Neck Squamous Cell Carcinoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.